| NDC Code | 63323-562-15 |
|---|
| Package Description | 10 VIAL, SINGLE-USE in 1 CARTON (63323-562-15) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (63323-562-41) |
|---|
| Product NDC | 63323-562 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Bivalirudin |
|---|
| Non-Proprietary Name | Bivalirudin |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20171030 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA090189 |
|---|
| Manufacturer | Fresenius Kabi USA, LLC |
|---|
| Substance Name | BIVALIRUDIN |
|---|
| Strength | 250 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA] |
|---|